Literature DB >> 31655311

Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma.

Caiyan Liu1, Shenshen Yang1, Kailong Wang1, Xiaomei Bao1, Yiman Liu1, Shiyue Zhou1, Hongwei Liu1, Yuling Qiu2, Tao Wang1, Haiyang Yu3.   

Abstract

Hepatocellular carcinoma (HCC) has become one of the major diseases that are threatening human health in the 21st century. Currently there are many approaches to treat liver cancer, but each has its own advantages and disadvantages. Among various methods of treating liver cancer, natural medicine treatment has achieved promising results because of their superiorities of high efficiency and availability, as well as low side effects. Alkaloids, as a class of natural ingredients derived from traditional Chinese medicines, have previously been shown to exert prominent anti-hepatocarcinogenic effects, through various mechanisms including inhibition of proliferation, metastasis and angiogenesis, changing cell morphology, promoting apoptosis and autophagy, triggering cell cycle arrest, regulating various cancer-related genes as well as pathways and so on. As a consequence, alkaloids suppress the development and progression of liver cancer. In this study, the mechanisms of representative alkaloids against hepatocarcinoma in each class are described systematically according to the structure classification, which mainly divides alkaloids into piperidine alkaloids, isoquinoline alkaloids, indole alkaloids, terpenoids alkaloids, steroidal alkaloids and other alkaloids. Besides using them alone, synergistic effects created together with other chemotherapy drugs and some special preparation methods also have been demonstrated. In this review, we have summarized the potential roles of several common alkaloids in the prevention and treatment of HCC, by revising the preclinical studies, highlighting the potential applications of alkaloids when they function as a therapeutic choice for HCC treatment, and integrating them into clinical practices.
Copyright © 2019 Tianjin University of Traditional Chinese Medicine. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Alkaloid; Hepatocellular carcinoma; Mechanism; Natural ingredient

Mesh:

Substances:

Year:  2019        PMID: 31655311     DOI: 10.1016/j.biopha.2019.109543

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  22 in total

1.  ROS-Mediated Anti-Tumor Effect of Coptidis Rhizoma against Human Hepatocellular Carcinoma Hep3B Cells and Xenografts.

Authors:  So Young Kim; Cheol Park; Min Yeong Kim; Seon Yeong Ji; Hyun Hwangbo; Hyesook Lee; Su Hyun Hong; Min Ho Han; Jin-Woo Jeong; Gi-Young Kim; Chang-Gue Son; JaeHun Cheong; Yung Hyun Choi
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

2.  Tomatine Displays Antitumor Potential in In Vitro Models of Metastatic Melanoma.

Authors:  Simona Serratì; Letizia Porcelli; Stefania Guida; Anna Ferretta; Rosa Maria Iacobazzi; Tiziana Cocco; Immacolata Maida; Gabriella Tamasi; Claudio Rossi; Michele Manganelli; Stefania Tommasi; Amalia Azzariti; Gabriella Guida
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

Review 3.  Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches.

Authors:  Zahra Farzaneh; Massoud Vosough; Tarun Agarwal; Maryam Farzaneh
Journal:  Cancer Cell Int       Date:  2021-04-13       Impact factor: 5.722

4.  Constructing the Logical Regression Model to Predict the Target of Jianpi Jiedu Decoction in the Treatment of Hepatocellular Carcinoma.

Authors:  Rongjie Zhang; Yan Chen; Ge Zhou; Baoguo Sun; Yue Li; Zexiong Chen
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-28       Impact factor: 2.629

Review 5.  Research Progress on the Antiosteoarthritic Mechanism of Action of Natural Products.

Authors:  Mingzhu Gao; Chun Chen; Qiaoyan Zhang; Jun Bian; Luping Qin; Leilei Bao
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-30       Impact factor: 2.629

Review 6.  Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension.

Authors:  Zhifeng Xue; Yixuan Li; Mengen Zhou; Zhidong Liu; Guanwei Fan; Xiaoying Wang; Yan Zhu; Jian Yang
Journal:  Front Pharmacol       Date:  2021-11-09       Impact factor: 5.810

7.  Ophiopogonin‑B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K/AKT and AMPK signaling pathways.

Authors:  Fang Yuan; Qian Gao; Hailin Tang; Jun Shi; Yiqun Zhou
Journal:  Mol Med Rep       Date:  2022-02-16       Impact factor: 2.952

Review 8.  Therapeutic Potential of Natural Plants Against Non-Alcoholic Fatty Liver Disease: Targeting the Interplay Between Gut Microbiota and Bile Acids.

Authors:  QinMei Sun; Xin Xin; ZiMing An; YiYang Hu; Qin Feng
Journal:  Front Cell Infect Microbiol       Date:  2022-03-09       Impact factor: 5.293

9.  The diagnostic value of PIVKA-II, AFP, AFP-L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma.

Authors:  Famei Qi; Aihua Zhou; Li Yan; Xiumei Yuan; Danni Wang; Ruoyun Chang; Yujun Zhang; Funa Shi; Xiaomei Han; Jinxia Hou; Lianhua Wei; Xu Zhang
Journal:  J Clin Lab Anal       Date:  2019-12-10       Impact factor: 2.352

10.  Efficacy and safety of Xiaoaiping injection for liver cancer: A protocol for systematic review and meta-analysis.

Authors:  Daorui Hou; Jian Xiong; Ya Li; Yahui Peng; Lu Xiong
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.